Bloomage BioTechnology Corporation Limited (688363.SS)
CNY 48.13
(-1.98%)
CNY 48.13
(-1.98%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 592.55 Million CNY | -38.97% |
| 2022 | 970.91 Million CNY | 24.11% |
| 2021 | 782.33 Million CNY | 21.13% |
| 2020 | 645.83 Million CNY | 10.29% |
| 2019 | 585.6 Million CNY | 38.16% |
| 2018 | 423.85 Million CNY | 90.7% |
| 2017 | 222.26 Million CNY | -17.5% |
| 2016 | 269.42 Million CNY | 41.51% |
| 2015 | 190.39 Million CNY | 17.48% |
| 2014 | 162.06 Million CNY | 71.68% |
| 2013 | 94.39 Million CNY | 5.74% |
| 2012 | 89.27 Million CNY | 0.0% |
| 2011 | - CNY | 0.0% |
| 2010 | - CNY | 0.0% |
| 2009 | - CNY | 0.0% |
| 2008 | - CNY | 0.0% |
| 2007 | - CNY | 0.0% |
| 2006 | - CNY | 0.0% |
| 2005 | - CNY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 20.25 Million CNY | -79.41% |
| 2024 Q2 | 98.39 Million CNY | -59.57% |
| 2024 Q1 | 243.36 Million CNY | 211.39% |
| 2023 FY | 592.55 Million CNY | -38.97% |
| 2023 Q2 | 224.12 Million CNY | 11.79% |
| 2023 Q1 | 200.48 Million CNY | -31.69% |
| 2023 Q3 | 89.79 Million CNY | -59.94% |
| 2023 Q4 | 78.15 Million CNY | -12.96% |
| 2022 Q2 | 273.47 Million CNY | 36.91% |
| 2022 Q4 | 293.47 Million CNY | 43.71% |
| 2022 FY | 970.91 Million CNY | 24.11% |
| 2022 Q3 | 204.21 Million CNY | -25.33% |
| 2022 Q1 | 199.75 Million CNY | -12.02% |
| 2021 Q3 | 194.74 Million CNY | -6.45% |
| 2021 FY | 782.33 Million CNY | 21.13% |
| 2021 Q1 | 152.39 Million CNY | -26.83% |
| 2021 Q2 | 208.16 Million CNY | 36.59% |
| 2021 Q4 | 227.03 Million CNY | 16.58% |
| 2020 Q3 | 170.5 Million CNY | 7.23% |
| 2020 Q1 | 108.04 Million CNY | -36.2% |
| 2020 Q2 | 159.01 Million CNY | 47.17% |
| 2020 FY | 645.83 Million CNY | 10.29% |
| 2020 Q4 | 208.27 Million CNY | 22.15% |
| 2019 Q1 | 107.21 Million CNY | 2.04% |
| 2019 Q3 | 151.18 Million CNY | -4.21% |
| 2019 FY | 585.6 Million CNY | 38.16% |
| 2019 Q4 | 169.35 Million CNY | 12.02% |
| 2019 Q2 | 157.84 Million CNY | 47.21% |
| 2018 FY | 423.85 Million CNY | 90.7% |
| 2018 Q4 | 105.07 Million CNY | -19.03% |
| 2018 Q3 | 129.76 Million CNY | 14.18% |
| 2018 Q2 | 113.64 Million CNY | 20.25% |
| 2018 Q1 | 94.51 Million CNY | 0.0% |
| 2017 Q2 | 40.52 Million CNY | 0.0% |
| 2017 Q1 | 40.52 Million CNY | -32.28% |
| 2017 FY | 222.26 Million CNY | -17.5% |
| 2016 Q4 | 59.83 Million CNY | 0.0% |
| 2016 Q2 | 54.21 Million CNY | 0.0% |
| 2016 FY | 269.42 Million CNY | 41.51% |
| 2016 Q3 | 59.83 Million CNY | 10.36% |
| 2016 Q1 | 54.21 Million CNY | 19.54% |
| 2015 Q4 | 45.35 Million CNY | 0.0% |
| 2015 FY | 190.39 Million CNY | 17.48% |
| 2015 Q3 | 45.35 Million CNY | -9.01% |
| 2015 Q2 | 49.84 Million CNY | 0.0% |
| 2015 Q1 | 49.84 Million CNY | 27.31% |
| 2014 Q1 | 41.88 Million CNY | 299.2% |
| 2014 Q3 | 39.15 Million CNY | -6.52% |
| 2014 FY | 162.06 Million CNY | 71.68% |
| 2014 Q4 | 39.15 Million CNY | 0.0% |
| 2014 Q2 | 41.88 Million CNY | 0.0% |
| 2013 Q2 | 36.7 Million CNY | 0.0% |
| 2013 Q3 | 10.49 Million CNY | -71.42% |
| 2013 Q4 | 10.49 Million CNY | 0.0% |
| 2013 FY | 94.39 Million CNY | 5.74% |
| 2013 Q1 | 36.7 Million CNY | 123.4% |
| 2012 FY | 89.27 Million CNY | 0.0% |
| 2012 Q4 | 16.43 Million CNY | 0.0% |
| 2012 Q3 | 16.43 Million CNY | 0.0% |
| 2011 FY | - CNY | 0.0% |
| 2010 FY | - CNY | 0.0% |
| 2009 FY | - CNY | 0.0% |
| 2008 FY | - CNY | 0.0% |
| 2007 FY | - CNY | 0.0% |
| 2006 FY | - CNY | 0.0% |
| 2005 FY | - CNY | 0.0% |